| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kronos Bio Inc (NASDAQ: KRON)
KRON Technical Analysis
5
| As on 9th Jun 2023 KRON STOCK Price closed @ 1.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.67 & Strong Sell for SHORT-TERM with Stoploss of 9.83 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KRONSTOCK Price
| Open | 1.68 | Change | Price | % |
| High | 1.74 | 1 Day | 0.03 | 1.80 |
| Low | 1.64 | 1 Week | 0.03 | 1.80 |
| Close | 1.70 | 1 Month | 0.21 | 14.09 |
| Volume | 246747 | 1 Year | -13.54 | -88.85 |
| 52 Week High 15.40 | 52 Week Low 1.24 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KRON Daily Charts |
KRON Intraday Charts |
Whats New @ Bazaartrend |
KRON Free Analysis |
|
|
KRON Important Levels Intraday
| RESISTANCE | 1.89 |
| RESISTANCE | 1.83 |
| RESISTANCE | 1.79 |
| RESISTANCE | 1.75 |
| SUPPORT | 1.65 |
| SUPPORT | 1.61 |
| SUPPORT | 1.57 |
| SUPPORT | 1.51 |
KRON Forecast May 2024
| 4th UP Forecast | 14.24 |
| 3rd UP Forecast | 10.22 |
| 2nd UP Forecast | 7.73 |
| 1st UP Forecast | 5.25 |
| 1st DOWN Forecast | -1.85 |
| 2nd DOWN Forecast | -4.33 |
| 3rd DOWN Forecast | -6.82 |
| 4th DOWN Forecast | -10.84 |
KRON Weekly Forecast
| 4th UP Forecast | 5.67 |
| 3rd UP Forecast | 4.40 |
| 2nd UP Forecast | 3.61 |
| 1st UP Forecast | 2.82 |
| 1st DOWN Forecast | 0.58 |
| 2nd DOWN Forecast | -0.21 |
| 3rd DOWN Forecast | -1.00 |
| 4th DOWN Forecast | -2.27 |
KRON Forecast2024
| 4th UP Forecast | 29.83 |
| 3rd UP Forecast | 20.81 |
| 2nd UP Forecast | 15.23 |
| 1st UP Forecast | 9.66 |
| 1st DOWN Forecast | -6.26 |
| 2nd DOWN Forecast | -11.83 |
| 3rd DOWN Forecast | -17.41 |
| 4th DOWN Forecast | -26.43 |
Kronos Bio Inc ( NASDAQ USA Symbol : KRON )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KRON Business Profile
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California. Address: 1300 South El Camino Real, San Mateo, CA, United States, 94402
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service